Kramer H, von Baehr R, Unger U
Allerg Immunol (Leipz). 1978;24(2):101-7.
Twenty one patients with lung cancer and twelve patients with unspecified lung disease were evaluated by means of delayed cutaneous hypersensitivity skin tests with tumour associated antigen. Nine of these patients with lung cancer and seven healthy persons were evaluated by in vitro assays of lymphocyte function to tumour associated antigen (TAA) from "Cancerotest Dessau". We did not find a statistically significant lymphocyte transformation to the testing concentration of TAA. For the same patients with lung cancer and controls we found statistically significant results of the mean lymphocyte transformation to phytohemagglutinin. It has been shown that the delayed cutaneous hypersensitivity skin tests demonstrated "false positive" reactions to TAA. It is possible that this is an expression of the irritative effects of TAA. It is estimated that the application of the antigens in this form presented and in this chosen examination conditions, does not allow for definite diagnostic assessment to be expected.
对21例肺癌患者和12例未明确诊断的肺部疾病患者进行了肿瘤相关抗原迟发性皮肤过敏试验评估。对其中9例肺癌患者和7名健康人进行了针对来自“德绍癌检”的肿瘤相关抗原(TAA)的淋巴细胞功能体外检测。我们未发现针对检测浓度的TAA有统计学显著意义的淋巴细胞转化。对于相同的肺癌患者和对照组,我们发现针对植物血凝素的平均淋巴细胞转化结果具有统计学显著意义。已表明,迟发性皮肤过敏试验对TAA显示出“假阳性”反应。这可能是TAA刺激作用的一种表现。据估计,以这种形式呈现的抗原并在这种选定的检测条件下应用,无法期望得到明确的诊断评估。